Type 2 diabetes in younger adults: the emerging UK epidemic
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
There is an emerging epidemic of type 2 diabetes (T2DM) in younger adults. They represent an extreme phenotype: likely to be obese, lead a sedentary lifestyle, have a strong family history of T2DM, be of black or minority ethnic origin, and come from less affluent socioeconomic groups. An accurate diagnosis of T2DM in younger adults, while essential to guide management, can be challenging even for the experienced diabetologist. Comorbidities such as hypertension, nephropathy and hyperlipidaemia are prevalent in this group, and, despite the lack of longitudinal data, they represent a very high risk group, with a need for aggressive management. This focused review of the epidemiology, aetiology, clinical outcomes, comorbidities and management of younger adults with T2DM will provide the non-specialist with up-to-date insight into the UK’s emerging epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early‐onset type 2 diabetes (EOT2D), defined as a diagnosis of type 2 diabetes (T2D) before the age of 40, is becoming a global health issue.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [2]
In the citing paper
“There are also legitimate reasons to segregate early onset adult type 2 diabetes from youth onset type 2 diabetes (diagnosed <18 years) when considering the provision of care to these individuals.”
From Developing services to support the delivery of care to people with early‐onset type 2 diabetes (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · cited 3×
“A ‘multi-hit’ hypothesis has been proposed to describe the pathogenesis of NAFLD.63 64 Insulin resistance and the associated increase in free fatty acids that are absorbed by the liver represent the first ‘hit’ and the development of steatosis.”
BackgroundInfluentialMetformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
Effect of Metformin in Pediatric Patients With Type 2 Diabetes
Jones, K. L., Arslanian, S., Peterokova, V. A., Park, J.-S., & Tomlinson, M. J. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.89 · Cited by 392
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369
Independent effects of physical activity in patients with nonalcoholic fatty liver disease #
St. George, A., Bauman, A., Johnston, A., Farrell, G., Chey, T., & George, J. (2009) · Hepatology · doi:10.1002/hep.22940 · Cited by 318
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin
Mauvais-Jarvis, F., Sobngwi, E., Porcher, R., Riveline, J.-P., Kevorkian, J.-P., Vaisse, C., Charpentier, G., Guillausseau, P.-J., Vexiau, P., & Gautier, J.-F. (2004) · Diabetes · doi:10.2337/diabetes.53.3.645 · Cited by 294
Characteristics of an Adult Population With Newly Diagnosed Type 2 Diabetes
Hillier, T. A., & Pedula, K. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1522 · Cited by 284
Cited by
Fernandez, S., DeMarni Cromer, L., Borntrager, C., Swopes, R., Hanson, R. F., & Davis, J. L. (2013) · Clinical Case Studies · doi:10.1177/1534650112462623 · Cited by 427
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
Bo, A., Thomsen, R. W., Nielsen, J. S., Nicolaisen, S. K., Beck‐Nielsen, H., Rungby, J., Sørensen, H. T., Hansen, T. K., Søndergaard, J., Friborg, S., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2968 · Cited by 62
Normal physical activity obliterates the deleterious effects of a high-caloric intake
Krogh-Madsen, R., Pedersen, M., Solomon, T. P. J., Knudsen, S. H., Hansen, L. S., Karstoft, K., Lehrskov-Schmidt, L., Pedersen, K. K., Thomsen, C., Holst, J. J., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00155.2013 · Cited by 53
Developing services to support the delivery of care to people with early‐onset type 2 diabetes
Misra, S., Gable, D., Khunti, K., Barron, E., Young, B., Kar, P., & Valabhji, J. (2022) · Diabetic Medicine · doi:10.1111/dme.14927 · Cited by 23
Self-citationCaba, M., Carvalho, M., Forbes, A., Forde, R., Gill, K., Khalifa, M., Parsons, J., Speight, J., Trief, P. M., & Hadjiconstantinou, M. (2026) · Diabetic Medicine · doi:10.1111/dme.70352 · Cited by 2
Metadata
- Authors
- Wilmot, E. G., Davies, M. J., Yates, T., Benhalima, K., Lawrence, I. G., & Khunti, K.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-21
- Volume
- 86
- Issue
- 1022
- Pages
- 711-718
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2128635750
- Cited by
- 72
- References
- 19
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.